Asklepios BioPharmaceutical Company
Gene therapy for rare diseases
Technology:
Neurological Disorders
Industry:
Gene Therapy
Headquarters:
North Carolina, United States
Founded Date:
2001
Funding Status:
M&A
Estimated Revenue:
$10M to $50M
Register and Claim Ownership